CD22 and COVID-19–associated multisystem inflammatory syndrome in children: The authors further showed that the dysfunction of Tregs from patients with MIS-C was CD22 dependent, as the suppressive capacities of these Tregs could be restored upon treatment with an anti-CD22 mAb in vitro (18).